Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Acquires Cell Sorting System from Propel Labs

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories has acquired a new cell sorting system from Propel Labs for an undisclosed amount, the Hercules, Calif.-based firm announced today.

Bio-Rad plans to begin shipping the benchtop sorting flow cytometer, called the S3 Cell Sorter, in January.

While cell sorting instruments are usually found in shared research service facilities because of their size, complexity, and maintenance, the S3 Cell Sorter will allow researchers to bring their cell sorting research onto their benchtops, Bio-Rad said.

"With this acquisition, we benefit from Propel Labs' years of expertise in cell sorting," Brad Crutchfield, president of the Life Science Group at Bio-Rad, said in a statement. "The S3 Cell Sorter fits in well with Bio-Rad's existing product workflow and will offer researchers greater access to targeting specific cells in their experiments and ultimately increasing the sensitivity of their assays."

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.